The survival time of neuroendocrine cancer patients is related to the type of pathology, whether it metastasizes or not and the timing of treatment. Neuroendocrine carcinoma is a malignant tumor of epithelial tissue with endocrine function, and there are four main types of carcinoid tumor, small cell carcinoma, atypical carcinoma and large cell neuroendocrine carcinoma. The prognosis of carcinoid tumor is better. After surgical resection, there is usually no metastasis or recurrence, and patients can survive for a longer time, even up to 10 years or more. Small cell carcinoma is more malignant and patients’ disease progresses more rapidly, and if treated timely, the 5-year survival rate is about 50%. The malignancy of atypical carcinoma is also higher, and the prognosis is not as good as the former. Large cell carcinoma has the highest malignancy and is prone to metastasis, with a 5-year survival rate of less than 20% after treatment. During the treatment period, patients should pay attention to keep sufficient rest, light diet, strengthen nutrition, and conduct appropriate physical activities to improve the body’s resistance to disease.